Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2022 | 3 |
2023 | 2 |
2024 | 1 |
Search Results
6 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Economic burden during remission and after relapse among older patients with newly diagnosed acute myeloid leukemia without hematopoietic stem cell transplant: A retrospective study using the SEER-Medicare database.
Leuk Res. 2023 Sep;132:107353. doi: 10.1016/j.leukres.2023.107353. Epub 2023 Jul 10.
Leuk Res. 2023.
PMID: 37562330
Free article.
The implementation of value-based frameworks, clinical care pathways, and alternative payment models for cancer care in the United States.
Panchal R, Brendle M, Ilham S, Kharat A, Schmutz HW, Huggar D, McBride A, Copher R, Au T, Willis C, Brixner D.
Panchal R, et al. Among authors: huggar d.
J Manag Care Spec Pharm. 2023 Sep;29(9):999-1008. doi: 10.18553/jmcp.2023.22352. Epub 2023 Jun 15.
J Manag Care Spec Pharm. 2023.
PMID: 37321967
Free PMC article.
Item in Clipboard
Economic burden in US patients with newly diagnosed acute myeloid leukemia receiving intensive induction chemotherapy.
Huggar D, Knoth RL, Copher R, Cao Z, Lipkin C, McBride A, LeBlanc TW.
Huggar D, et al.
Future Oncol. 2022 Oct;18(32):3609-3621. doi: 10.2217/fon-2022-0706. Epub 2022 Oct 28.
Future Oncol. 2022.
PMID: 36305495
Item in Clipboard
Indirect treatment comparison of oral versus injectable azacitidine as maintenance therapy for acute myeloid leukemia.
Tabah A, Huggar D, Wang ST, Johnson SJ, Copher RM, O'Connell T, McBride A, LeBlanc TW.
Tabah A, et al. Among authors: huggar d.
Future Oncol. 2022 Dec 12. doi: 10.2217/fon-2022-0820. Online ahead of print.
Future Oncol. 2022.
PMID: 36507931
Item in Clipboard
Treatment patterns and outcomes with luspatercept in patients with lower-risk myelodysplastic syndromes: A retrospective US cohort analysis.
Mukherjee S, Brown-Bickerstaff C, Falkenstein A, Makinde AY, Bland E, Laney J, Garretson M, Huggar D, McBride A.
Mukherjee S, et al. Among authors: huggar d.
Hemasphere. 2024 Jan 30;8(1):e38. doi: 10.1002/hem3.38. eCollection 2024 Jan.
Hemasphere. 2024.
PMID: 38434524
Free PMC article.
No abstract available.
Item in Clipboard
The impact of remission duration on the long-term economic burden of acute myeloid leukemia among patients without hematopoietic stem cell transplant in the United States.
Tabah A, Brady BL, Huggar D, Jariwala-Parikh K, Huey K, Copher R, LeBlanc TW.
Tabah A, et al. Among authors: huggar d.
J Med Econ. 2022 Jan-Dec;25(1):903-911. doi: 10.1080/13696998.2022.2091879.
J Med Econ. 2022.
PMID: 35723576
Free article.
Item in Clipboard
Cite
Cite